The study results were published recently [48] and indicated that liraglutide did not improve clinical stability but was rather associated with a numerical but not statistically significant increase in the composite of death or HF hospitalization compared with placebo
Metformin, Trulicity, Mounjaro, Victoza, and Rybelsus are alternatives to Semaglutide for diabetes treatment
Participants received a GLP-1 between 2015 and 2025 and had MS clinic visits within 1 year before and at least 1 month after treatment initiation
Theres some research behind it for blood sugar regulation
According to Lake, participants also experienced an average weight loss of around 17 pounds in the 24 weeks, with significant improvements in glucose, insulin resistance and triglyceride levels
People asking, "What is Zepbound?" can rest assured that this medication is backed by robust clinical data proving its efficacy in weight management